Vibrational Spectroscopic Investigations of Glutamate Receptor
谷氨酸受体的振动光谱研究
基本信息
- 批准号:7393691
- 负责人:
- 金额:$ 22.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-10 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAllosteric RegulationBehaviorBindingBinding ProteinsCellsChemicalsClassificationCleaved cellClosureComplexConditionCoupledCysteineDNA Sequence RearrangementDataDevelopmentDockingDrug DesignEpilepsyEquilibriumEventExhibitsFluorescence Resonance Energy TransferGlutamate ReceptorGlutamatesGoalsIndividualInvestigationIon ChannelIonsIschemiaKineticsLaboratoriesLigand BindingLigand Binding DomainLigandsMapsMeasurementMeasuresMediatingMediator of activation proteinMembraneMethodsMolecularMonitorMutationNatureNeuraxisNeurotransmitter ReceptorPathway interactionsPhasePlayPositioning AttributeProcessPropertyProteinsRangeReportingResearch PersonnelResolutionRoleSeriesSideSignal TransductionSiteSpectroscopy, Fourier Transform InfraredSpectrum AnalysisStructureTestingTimeWorkalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acidamino 3 hydroxy 5 methylisoxazole 4 propionatebasecarboxylatedesensitizationextracellularkainatemutantneuropathologyprogramsreceptorreceptor functionresponsestopped-flow fluorescence
项目摘要
DESCRIPTION (provided by applicant): The specific molecular interactions between glutamate and the glutamate receptor are central to the allosteric regulation of function in this membrane bound protein, which is main excitatory neurotransmitter receptor in the mammalian central nervous system. Recent spectroscopic investigations of the isolated ligand-binding domain of the glutamate receptor in the apo and ligand bound forms provide a first view of such interactions. What is now needed is a more detailed understanding of the role of these chemical interactions in mediating the sequence of conformational changes that ultimately regulate ion flow. We propose to address this goal using two strategies. First, using a panel of mutants that exhibit a wide range of activities we will identify changes in specific ligand protein interactions using vibrational spectroscopy and correlate these to changes in the cleft closure conformational change in the ligand binding domain using fluorescence resonance energy transfer measurements. The changes thus identified in the ligand binding domain will then be contextualized in terms of changes in receptor function that will be studied by electrophysiological measurements. Secondly, we will monitor the kinetic events in the ligand binding domain and correlate these to the functional consequences in the receptor, i.e., activation and desensitization. For such a correlation, a panel of mutants that are known to alter one or more of the kinetic steps in the ligand binding domain will be used and the specific effects on the structural changes in the ligand binding domain as well as corresponding changes in function will be investigated. These equilibrium and kinetic investigations will provide comprehensive understanding of the changes at the molecular level that drive the changes in the large conformational changes in the ligand binding domain and eventually control the functional changes of the ion channel. More importantly, such correlations will aid in bridging the gap between studies on the isolated ligand-binding domain and the behavior of the intact receptor, and provide a basis for rational design of drugs aimed at modulating the function of this important protein which is known to play an important role in diverse neuropathologies, including epilepsy and ischemia.
描述(申请人提供):谷氨酸和谷氨酸受体之间的特定分子相互作用是这种膜结合蛋白功能变构调节的中心,它是哺乳动物中枢神经系统中主要的兴奋性神经递质受体。最近对载脂蛋白和配体结合形式的谷氨酸受体的分离配体结合域的光谱研究提供了这种相互作用的第一个视角。现在需要的是更详细地了解这些化学相互作用在调节最终调节离子流动的构象变化序列中所起的作用。我们建议使用两种策略来解决这一目标。首先,使用一组显示出广泛活性的突变体,我们将使用振动光谱确定特定配体蛋白质相互作用的变化,并使用荧光共振能量转移测量将这些变化与配体结合结构域中的裂隙闭合构象变化相关联。因此,在配基结合域中确定的变化将根据受体功能的变化来确定,这将通过电生理测量进行研究。其次,我们将监测配体结合域中的动力学事件,并将这些事件与受体中的功能结果关联起来,即激活和脱敏。对于这种相关性,将使用一组已知改变配体结合结构域中的一个或多个动力学步骤的突变体,并将研究对配体结合结构域中结构变化的特定影响以及相应的功能变化。这些平衡和动力学研究将在分子水平上提供全面的了解,这些变化驱动配基结合域的大构象变化,并最终控制离子通道的功能变化。更重要的是,这种相关性将有助于弥合对分离的配体结合结构域和完整受体行为的研究之间的差距,并为合理设计旨在调节这一重要蛋白质功能的药物提供基础,该蛋白质已知在包括癫痫和脑缺血在内的多种神经病理中发挥重要作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vasanthi Jayaraman其他文献
Vasanthi Jayaraman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vasanthi Jayaraman', 18)}}的其他基金
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 22.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 22.97万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)